We are live on ! Find out more
PRC

Pearl River Capital Portfolio holdings

AUM $630M
1-Year Est. Return 17.08%
This Fund
S&P 500
This Quarter Est. Return
+11.57%
1 Year Est. Return
+17.08%
3 Year Est. Return
+20.29%
5 Year Est. Return
+57.93%
10 Year Est. Return
–
AUM
$590M
AUM Growth
+$51.8M
Cap. Flow
+$16.7M
Cap. Flow %
2.83%
Top 10 Hldgs %
10.58%
Holding
599
New
158
Increased
165
Reduced
167
Closed
108

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.41M
2
XOM icon
ExxonMobil
XOM
+$8.17M
3
AAPL icon
Apple
AAPL
+$4.15M
4
TXN icon
Texas Instruments
TXN
+$4.09M
5
ADBE icon
Adobe
ADBE
+$3.93M

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$7M
2
DIS icon
Walt Disney
DIS
+$6.98M
3
MSFT icon
Microsoft
MSFT
+$6.69M
4
RTX icon
RTX Corp
RTX
+$5.96M
5
MRK icon
Merck
MRK
+$5.73M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 15.61%
2 Technology 15.28%
3 Healthcare 14.63%
4 Industrials 12.62%
5 Financials 12.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
T icon
576
AT&T
T
$159B
– –
-25,486
Closed -$391K
TECH icon
577
Bio-Techne
TECH
$11.2B
– –
-4,040
Closed -$287K
TFC icon
578
Truist Financial
TFC
$64.3B
– –
-22,416
Closed -$976K
TTWO icon
579
Take-Two Interactive
TTWO
$45.2B
– –
-12,778
Closed -$1.39M
TWLO icon
580
Twilio
TWLO
$30.1B
– –
-4,674
Closed -$323K
UAA icon
581
Under Armour
UAA
$2.89B
– –
-27,267
Closed -$181K
ULTA icon
582
Ulta Beauty
ULTA
$23.3B
– –
-3,875
Closed -$1.55M
VIAV icon
583
Viavi Solutions
VIAV
$10.1B
– –
-20,168
Closed -$263K
VTR icon
584
Ventas
VTR
$46B
– –
-20,743
Closed -$833K
WBA
585
DELISTED
Walgreens Boots Alliance
WBA
– –
-14,217
Closed -$446K
WM icon
586
Waste Management
WM
$90B
– –
-3,833
Closed -$614K
WST icon
587
West Pharmaceutical
WST
$24.4B
– –
-1,383
Closed -$340K
XEL icon
588
Xcel Energy
XEL
$48.5B
– –
-9,091
Closed -$582K
XPO icon
589
XPO
XPO
$23.6B
– –
-22,096
Closed -$585K
ZION icon
590
Zions Bancorporation
ZION
$10.5B
– –
-5,855
Closed -$298K
NKLA
591
DELISTED
Nikola Corporation Common Stock
NKLA
– –
-838
Closed -$88K
SMAR
592
DELISTED
Smartsheet Inc.
SMAR
– –
-10,317
Closed -$354K
CTLT
593
DELISTED
CATALENT, INC.
CTLT
– –
-3,356
Closed -$243K
CANO
594
DELISTED
Cano Health, Inc.
CANO
– –
-138
Closed -$120K
SYNH
595
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
– –
-11,675
Closed -$550K
IAA
596
DELISTED
IAA, Inc. Common Stock
IAA
– –
-12,427
Closed -$396K
COUP
597
DELISTED
Coupa Software Incorporated
COUP
– –
-12,247
Closed -$720K
ONEM
598
DELISTED
1Life Healthcare
ONEM
– –
-18,106
Closed -$311K
HZNP
599
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
– –
-5,896
Closed -$365K
20 21 22 23
24

Similar funds

SCM
Sahana Capital Management Greenwich, Connecticut $645M AUM 23.48% 1-Year Est. Return
IFAM
Institutional & Family Asset Management Fort Collins, Colorado $654M AUM 12.29% 1-Year Est. Return
GIM
Greylin Investment Management Orange, Virginia $598M AUM 18.59% 1-Year Est. Return
MCM
McKinley Capital Management Anchorage, Alaska $571M AUM 36.44% 1-Year Est. Return
AT
Arden Trust Wilmington, Delaware $716M AUM 17.63% 1-Year Est. Return
AC
Abbrea Capital Greenbrae, California $755M AUM 24.68% 1-Year Est. Return
PWS
Private Wealth Strategies New Albany, Ohio $498M AUM 17.23% 1-Year Est. Return
RVPG
Relative Value Partners Group $772M AUM 15.6% 1-Year Est. Return

Pearl River Capital's Q4 2022 Portfolio in Review

As of Q4 2022, Pearl River Capital held 599 positions worth $590M, up 9.6% from $538M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pearl River Capital's Q4 2022 filing shows 158 new, 165 increased, 167 reduced and 108 closed positions. Its largest new stake was Bristol-Myers Squibb: 111,556 shares worth $8.03M. The largest sale was Pfizer, an estimated $7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.

  • Pearl River Capital's largest Q4 2022 buy was Bristol-Myers Squibb: 111,556 shares worth $8.03M.
  • Pearl River Capital added most to Honeywell in Q4 2022, an estimated $3.3M increase.
  • Pearl River Capital's biggest Q4 2022 reduction was Qualcomm, cutting an estimated $5.05M.
  • Pearl River Capital fully exited Pfizer in Q4 2022, selling an estimated $7M.
  • Pearl River Capital's ten largest holdings make up 11% of its $590M portfolio in Q4 2022.
  • Pearl River Capital opened 158 new positions and closed 108 in Q4 2022.
  • Pearl River Capital's portfolio value rose 9.6% quarter-over-quarter to $590M.

Based on Pearl River Capital's 13F filing for Q4 2022, filed 13 Feb 2023.